Stoke Therapeutics, Inc. · NASDAQ:STOK
BlackRock, Inc. reported a 5.80% stake in Stoke Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 16, 2025
BlackRock, Inc. reported a 5.80% stake in Stoke Therapeutics, Inc., 3,118,934 shares, as a passive investor on Mar 31, 2025. Filed Apr 16, 2025 (Schedule 13G/A).
- Stake
- 5.80%
- Shares
- 3,118,934
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.80% | 3,118,934 |
Source
Related
- Stoke Therapeutics, Inc.
- BlackRock, Inc.
- Stoke Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Oct 17, 2025
- Form 4 · Allan Jonathan · Oct 2, 2026
- Form 4 · Ticho Barry · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Sep 30, 2026
- Form 4 · Ticho Barry · Sep 3, 2026
- Form 4 · Ticho Barry · Aug 18, 2026